Consortium program with the purpose of organizing several non-commercial clinical trials and follow-up research projects in respect of Covid19 vaccines in order to generateinformation and data that might be useful to patients, the clinical practice and/or policy decision makers.

Project Details

Description

BelCoVac brings together all the clinical studies on COVID-19 vaccination in different vulnerable populations (e.g. elderly people, cancer patients, kidney transplant patients, kidney dialysis patients, lung transplant patients,...). The virology lab of ITM is providing all the readouts of the neutralizing antibody capacity in live-virus neutralization tests with all coronavirus variants of concern.

Description

BelCoVac brings together all the clinical studies on COVID-19 vaccination in different vulnerable populations (e.g. elderly people, cancer patients, kidney transplant patients, kidney dialysis patients, lung transplant patients,...). The virology lab of ITM is providing all the readouts of the neutralizing antibody capacity in live-virus neutralization tests with all coronavirus variants of concern.
AcronymBelCoVac studie
StatusFinished
Effective start/end date18/01/2131/12/23

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.